Aspartate β-Hydroxylase (ASPH) Expression in Acute Myeloid Leukemia: A Potential Novel Therapeutic Target.
Saved in:
| Title: | Aspartate β-Hydroxylase (ASPH) Expression in Acute Myeloid Leukemia: A Potential Novel Therapeutic Target. |
|---|---|
| Authors: | Holtzman NG; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD, United States.; Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States., Lebowitz MS; Sensei Biotherapeutics Inc., Gaithersburg, MD, United States., Koka R; Department of Pathology, University of Maryland School of Medicine, Baltimore, MD, United States., Baer MR; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD, United States.; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, United States., Malhotra K; Sensei Biotherapeutics Inc., Gaithersburg, MD, United States., Shahlaee A; Sensei Biotherapeutics Inc., Gaithersburg, MD, United States., Ghanbari HA; Sensei Biotherapeutics Inc., Gaithersburg, MD, United States., Bentzen SM; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD, United States.; Department of Epidemiology and Biostatistics, University of Maryland School of Medicine, Baltimore, MD, United States., Emadi A; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD, United States.; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, United States.; Department of Pharmacology, University of Maryland School of Medicine, Baltimore, MD, United States. |
| Source: | Frontiers in oncology [Front Oncol] 2021 Dec 22; Vol. 11, pp. 783744. Date of Electronic Publication: 2021 Dec 22 (Print Publication: 2021). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
